Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Becton Dickinson and Company

BDX
Current price
236.3 USD -0.79 USD (-0.33%)
Last closed 236.62 USD
Company www.bd.com
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NYSE
Capitalization 68 292 120 576 USD
Yield for 12 month -5.87 %
1Y
3Y
5Y
10Y
15Y
BDX
21.11.2021 - 28.11.2021

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey. Address: 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

275.27 USD

P/E ratio

50.4915

Dividend Yield

1.61 %

Current Year

+19 372 000 000 USD

Last Year

+18 870 000 000 USD

Current Quarter

+5 045 000 000 USD

Last Quarter

+4 706 000 000 USD

Current Year

+8 170 000 000 USD

Last Year

+8 477 000 000 USD

Current Quarter

+2 304 000 000 USD

Last Quarter

+2 027 000 000 USD

Key Figures BDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 5 070 000 128 USD
Operating Margin TTM 16.43 %
PE Ratio 50.4915
Return On Assets TTM 3.2 %
PEG Ratio 1.3383
Return On Equity TTM 5.37 %
Wall Street Target Price 275.27 USD
Revenue TTM 19 715 999 744 USD
Book Value 88.74 USD
Revenue Per Share TTM
Dividend Share 3.72 USD
Quarterly Revenue Growth YOY 4.6 %
Dividend Yield 1.61 %
Gross Profit TTM 8 823 000 000 USD
Earnings per share 4.68 USD
Diluted Eps TTM 4.68 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY 20.9 %
Profit Margin 6.76 %

Dividend Analytics BDX

Aristocrat - 25 or more consecutive years of dividend increases

Dividend growth over 5 years

25 %

Continuous growth

41 year

Payout Ratio 5 years average

68 %

Dividend History BDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 3.8
Ex Dividend Date 10.06.2024
Forward Annual Dividend Yield 1.61 %
Last Split Factor 1025:1000
Payout Ratio 30.74 %
Last Split Date 01.04.2022
Dividend Date 28.06.2024

Stock Valuation BDX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 50.4915
Forward PE 17.3611
Enterprise Value Revenue 4.2514
Price Sales TTM 3.4856
Enterprise Value EBITDA 19.3484
Price Book MRQ 2.6819

Financials BDX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BDX

For 52 weeks

228 USD 284.02 USD
50 Day MA 237.99 USD
Shares Short Prior Month 2 925 795
200 Day MA 247.82 USD
Short Ratio 2.04
Shares Short 2 168 712
Short Percent 0.75 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

420.21 USD Microsoft Corporation -1.96 (-0.46%)
Detailed analytics

ETF funds


S

SX7EEX

14.76 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.11 (+0.7%)
Detailed analytics

Metals


Gold

2441.48 USD Gold +26.8 (+1.11%)
Detailed analytics